Biomedical engineers at Duke University have developed an AI-based platform that designs short proteins, termed peptides, capable of binding and destroying previously undruggable disease-causing proteins.
EC grants expanded indication approval for Merck’s Ebola vaccine
Ervebois is indicated for active immunisation of the paediatric population against Zaire ebolavirus-caused Ebola virus disease. Credit: Novikov Aleksey / Shutterstock.com. The European Commission (EC)